Add like
Add dislike
Add to saved papers

Further contribution to the life history of Centrocestus formosanus (Nishigori, 1924) Price, 1932 (Trematoda: Heterophyidae) with special reference to a new first intermediate host from the South Western Ghats, India.

Centrocestus formosanus is a zoonotic small invasive heterophyid fluke with worldwide distribution. Its three-host life cycle requires a thiarid snail as first intermediate host, fishes as second intermediate hosts and piscivorous birds and mammals as definitive hosts for completion. As far as is known, the only first intermediate host being utilized, globally, by this parasite is the snail, Melanoides tuberculata. In the present study, life cycle stages of C. formosanus were recovered naturally and successfully tested in the laboratory. Study also adds a new host to its life cycle, the snail Bithynia (Digoniostoma) pulchella, as the first intermediate host with natural infection. Parasitological descriptors (prevalence, mean intensity and mean abundance) of infection were measured for each host. Being an invasive parasite, addition of a new host to C. formosanus life cycle has notable ecological and evolutionary significance.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app